14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of BLPH
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Volatile ride for Bellerophon Therapeutics stock price on Wednesday moving between $0.0522 and $0.0612
(Updated on Apr 24, 2024)

Sell candidate since Apr 24, 2024 PDF

The Bellerophon Therapeutics stock price fell by -7.68% on the last day (Wednesday, 24th Apr 2024) from $0.0586 to $0.0541. During the last trading day the stock fluctuated 17.21% from a day low at $0.0522 to a day high of $0.0612. The price has fallen in 5 of the last 10 days and is down by -9.83% for this period. Volume has increased on the last day by 42 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 47 thousand shares were bought and sold for approximately $2.54 thousand.

The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -3.70% during the next 3 months and, with a 90% probability hold a price between $0.0465 and $0.0574 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

BLPH Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Bellerophon Therapeutics stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.0549 and $0.0551. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, April 10, 2024, and so far it has fallen -9.83%. Further fall is indicated until a new bottom pivot has been found. Bellerophon Therapeutics gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". The very low volume increases the risk and reduces the other technical signals issued.

Sell
Special Signal Notification

Double Top Formation

Double Top Formation A sell signal from a double top formation was found on Wednesday, April 10, 2024 with a target of $0.0578. Despite whether the objective of the signal formation has been reached the stock may continue to fall.

Support, Risk & Stop-loss for Bellerophon Therapeutics stock

Bellerophon Therapeutics finds support from accumulated volume at $0.0535 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.0090 between high and low, or 17.21%. For the last week, the stock has had daily average volatility of 7.25%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (BLPH) For The Upcoming Trading Day Of Thursday 25th

For the upcoming trading day on Thursday, 25th we expect Bellerophon Therapeutics to open at $0.0558, and during the day (based on 14 day Average True Range), to move between $0.0488 and $0.0594, which gives a possible trading interval of +/-$0.0053 (+/-9.82%) up or down from last closing price. If Bellerophon Therapeutics takes out the full calculated possible swing range there will be an estimated 19.64% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.0535 (1.11%) than the resistance at $0.0550 (1.66%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Bellerophon Therapeutics stock A Buy?

Bellerophon Therapeutics holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Sell candidate.

Current score: -2.430 Sell Candidate Downgraded

Predicted Opening Price for Bellerophon Therapeutics of Thursday, April 25, 2024

Fair opening price April 25, 2024 Current price
$0.0558 ( 3.19%) $0.0541

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for BLPH

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.0648 19.80 %
R2 0.0614 13.46 %
R1 0.0593 9.54 %
Current price: 0.0541
Support S1 0.0524 -3.15 %
S2 0.0503 -7.07 %
S3 0.0468 -13.41 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.0640 18.30 %
R2 0.0610 12.75 %
R1 0.0550 1.66 %
Current price 0.0541
Support S1 0.0535 -1.11%
S2 0.0533 -1.57%
S3 0.0510 -5.73%

FAQ

What is the symbol for Bellerophon Therapeutics Stock and on which exchange is it traded?
The symbol for Bellerophon Therapeutics is BLPH and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Bellerophon Therapeutics Stock?
Bellerophon Therapeutics holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Sell candidate.

How to buy Bellerophon Therapeutics Stock?
Bellerophon Therapeutics Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Bellerophon Therapeutics Stock.

What's the current price of Bellerophon Therapeutics Stock?
As of the end of day on the Apr 24, 2024, the price of an Bellerophon Therapeutics (BLPH) share was $0.0541.

What is the 52-week high and low for Bellerophon Therapeutics Stock?
The 52-week high for Bellerophon Therapeutics Stock is $11.15 and the 52-week low is $0.0290.

What is the market capitalization of Bellerophon Therapeutics Stock?
As of the Apr 24, 2024, the market capitalization of Bellerophon Therapeutics is 661.784K.

When is the next earnings date for Bellerophon Therapeutics?
The upcoming earnings date for Bellerophon Therapeutics is May 13, 2024.
Click to get the best stock tips daily for free!

About Bellerophon Therapeutics

Bellerophon Therapeutics Bellerophon Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development of products for the treatment of cardiopulmonary diseases in the United States. Its product includes INOpulse, a proprietary pulsatile nitric oxide delivery platform for the treatment of pulmonary hypertension. The company engages in the development of INOpulse that is in Phase 3 clinical trial for the treatment of pulmonary hypertension associated w... BLPH Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT